La hiponatremia en la insuficiencia cardíaca: fisiopatología y enfoque farmacológico

Endocrinología y Nutrición - Tập 57 - Trang 10-14 - 2010
Gina González Robledo1, Diana Silva Cantillo1, Josep Comín Colet1
1Programa de Insuficiencia Cardíaca, Servicio de Cardiología, Hospital del Mar (IMAS), Barcelona, España

Tài liệu tham khảo

Kearney, 2002, Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure, J Am Coll Cardiol, 40, 1801, 10.1016/S0735-1097(02)02490-7

Sica, 2006, Sodium and water retention in heart failure and diuretic therapy: basic mechanisms, Cleve Clin J Med, 73, S2, 10.3949/ccjm.73.Suppl_2.S2

Lee, 2003, Vasopressin: a new target for the treatment of heart failure, Am Heart J, 146, 9, 10.1016/S0002-8703(02)94708-3

Rosner, 2009, Hyponatremia in heart failure: the role of arginine vasopressin and diuretics, Cardiovasc Drugs Ther, 23, 307, 10.1007/s10557-009-6180-9

Dunn, 1973, The role of blood osmolality and volume in regulating vasopressin secretion in the rat, J Clin Invest, 52, 3212, 10.1172/JCI107521

Goldsmith, 2006, The role of vasopressin in congestive heart failure, Cleve Clin J Med, 73, S19, 10.3949/ccjm.73.Suppl_3.S19

Francis, 1990, Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies Of Left Ventricular Dysfunction (SOLVD), Circulation, 82, 1724, 10.1161/01.CIR.82.5.1724

Klein, 2005, Circulation, 111, 2454, 10.1161/01.CIR.0000165065.82609.3D

Greenberg, 2000, Diuretic Complications, Am J Med Sci, 319, 10, 10.1097/00000441-200001000-00002

Burnier, 1992, Neurohormonal consequences of diuretics in different cardiovascular syndromes, Eur Heart J, 13, 28, 10.1093/eurheartj/13.suppl_G.28

Adrogue, 2000, Hyponatremia, N Engl J Med, 342, 1581, 10.1056/NEJM200005253422107

Ellison, 2007, Clinical practice. The syndrome of inappropriate antidiuresis, N Engl J Med, 356, 2064, 10.1056/NEJMcp066837

Hoorn, 2008, Hyponatremia revisited: translating physiology to practice, Nephron Physiol, 108, 46, 10.1159/000119709

Sonnenblick, 1993, Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients, Chest, 103, 601, 10.1378/chest.103.2.601

Decaux, 2008, Non-peptide arginine-vasopressin antagonists: the vaptans, Lancet, 371, 1624, 10.1016/S0140-6736(08)60695-9

Gheorghiade, 2003, Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial, Circulation, 107, 2690, 10.1161/01.CIR.0000070422.41439.04

Gheorghiade, 2004, Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial, JAMA, 291, 1963, 10.1001/jama.291.16.1963

Goldsmith, 2009, Treatment options for hyponatremia in heart failure, Heart Fail Rev, 14, 65, 10.1007/s10741-008-9110-1

Udelson, 2001, Acute hemodynamic effects of conivaptan, a dual V(1a) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure, Circulation, 104, 2417, 10.1161/hc4501.099313

THE BALANCE Study: treatment of hyponatremia based on lixivaptan in NYHA class III/IV cardiac patient evaluation. clinical trials.gov. 14122009. U.S National Institutes of Health, Web. 11 Jan 2010. Disponible en: http://clinicaltrials.gov/ct2/show/NCT00578695

Thông tin
Thông tin xuất bản

Endocrinología y Nutrición

Tập 57

10-14

Thông tin tác giả